Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 272

Results For "ABLE"

5290 News Found

Marksans Pharma completes acquisition of manufacturing site from Tevapharm India
News | April 20, 2023

Marksans Pharma completes acquisition of manufacturing site from Tevapharm India

Marksans will continue to supply existing products until the end of 2023 to Teva's affiliates, ensuring high-quality standards


Jubilant Ingrevia commissions acetic anhydride plant at Bharuch
News | April 20, 2023

Jubilant Ingrevia commissions acetic anhydride plant at Bharuch

This plant adds around 60,000 MT of capacity, scaling Jubilant Ingrevia Limited’s overall annual Acetic Anhydride capacity to 210,000 MT


Healthcare leaders focused on addressing staff shortages: Report
Digitisation | April 19, 2023

Healthcare leaders focused on addressing staff shortages: Report

Healthcare leaders are heavily investing in AI or plan to do so for both critical decision support and operational efficiency, helping tackle staff shortages


Multiple sclerosis market to generate sales of $29.8 billion by 2030, forecasts GlobalData
News | April 19, 2023

Multiple sclerosis market to generate sales of $29.8 billion by 2030, forecasts GlobalData

Several late-stage pipeline products have the potential to address some of these unmet needs


Enterprise Informatics central to solving productivity, staff and patient experience challenges, says Philips
Digitisation | April 18, 2023

Enterprise Informatics central to solving productivity, staff and patient experience challenges, says Philips

Digitization has unleashed a flood of data that presents a huge opportunity but is also overwhelming clinicians, nurses, and administrators


DualityBio collaborates with BioNTech to accelerate development of differentiated antibody-drug conjugate therapeutics
Biotech | April 18, 2023

DualityBio collaborates with BioNTech to accelerate development of differentiated antibody-drug conjugate therapeutics

WuXi Bio provided technical services, based on the companies' versatile integrated service platforms, to support various manufacturing and process development activities of these ADC product candidates.


Agilent showcases cancer portfolio Solutions at AACR 2023
Digitisation | April 18, 2023

Agilent showcases cancer portfolio Solutions at AACR 2023

From cancer research to diagnostic solutions


Merck acquires Prometheus Biosciences for US$10.8 billion to strengthen immunology pipeline
News | April 17, 2023

Merck acquires Prometheus Biosciences for US$10.8 billion to strengthen immunology pipeline

Prometheus Biosciences’ comprehensive data set enables target discovery and precision medicine approach in inflammation and immunology


Molbio Diagnostics and SigTuple join hands to build next-gen diagnostic testing devices
Clinical Trials | April 17, 2023

Molbio Diagnostics and SigTuple join hands to build next-gen diagnostic testing devices

The blood test market worldwide is today around $75-80 billion


Zydus receives final approval from the USFDA for Isoproterenol Hydrochloride Injection
Drug Approval | April 17, 2023

Zydus receives final approval from the USFDA for Isoproterenol Hydrochloride Injection

Isoproterenol hydrochloride injection is indicated to improve hemodynamic status in patients in distributive shock and shock due to reduced cardiac output